Hughes Steven George
Chief Medical Officer
Hughes Steven George has filed 9 SEC Form 4 filings (21 transaction rows) across 2 companies, including RNA, RNAM, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 22, 2026.
On the most recent filing, Hughes Steven George is listed as Chief Medical Officer at Avidity Biosciences, Inc. Inside the rolling window, Hughes Steven George reported no open-market purchases and 3 open-market sales totaling $631K in RNA. The largest disclosed transaction in the window is a sale of 4,895 RNA shares on Jan 21, 2026, worth $355K.
Companies traded
Other insiders at RNA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$631K
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Hughes Steven George made?
Hughes Steven George has filed 9 SEC Form 4 filings (21 transaction rows) across 2 companies, including RNA, RNAM since 2025.
Which companies does Hughes Steven George trade?
Hughes Steven George has filed SEC Form 4 disclosures for 2 companies, including RNA, RNAM.
When was Hughes Steven George's most recent SEC Form 4 filing?
Hughes Steven George's most recent SEC Form 4 filing on Tracefour is dated Sep 22, 2026.
What is Hughes Steven George's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Hughes Steven George is listed as Chief Medical Officer.
What is Hughes Steven George's total buy and sell value in the current window?
Inside the rolling retention window, Hughes Steven George bought $0 and sold $631K based on SEC Form 4 filings.
What was Hughes Steven George's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,895 RNA shares on 2026-01-21, worth $355K, per SEC Form 4 filings.